|
|
|
Partners
|
The World Health Organization Collaborating Center in Pharmaceutical Policy is jointly formed by
the following organizations:
|
|
The Center for International Health and Development (CIHD) is a team of clinicians, social
scientists and economists. These professionals strive to improve the health and quality of life of people
throughout the developing world by conducting applied research that treats health as a medical, social
development, and economic issue.
|
The major activities of the Center fall into three areas:
Improving child health and survival
Managing the social and economic impacts of the AIDS epidemic
Building the capacity of developing country researchers and research institutions
|
|
|
The Department of Ambulatory Care and Prevention (DACP) is jointly sponsored by Harvard
Medical School and Harvard Pilgrim Health Care. The nation's only medical school department that is
jointly sponsored by a health plan, DACP is actively engaged in both research and teaching.
|
The DACP leads in the creation and dissemination of new knowledge and skills essential to
maximizing the health of defined populations within available resources. The DACP programs are
divided into seven areas of focus:
Promoting health through prevention
Improving the quality and cost effectiveness of medical care
Understanding and overcoming disparities in care
Using information technology to improve and protect health
Using evidence to build sound policy
Creating national and global partnerships for health research
Training the next generation of clinical, research, and health systems leaders
The WHOCCPP is also the home of the
Boston International Network for the Rational Use of Drugs (INRUD) Group.
|
|
|
LATEST UPDATES
WHOCCPP
awarded funding for Interdisciplinary
Research and Training for Improving
Access to and Use of Medicines in China by Harvard
China Fund
Upcoming Courses
MedIC
Initiative Courses in Accra, Ghana, November 16-25, 2008
and Beijing, China in the Spring of 2009
|
